System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Pierre Vabres is an expert in Dermatology at Centre Hospitalier Universitaire Dijon Bourgogne (France). As of October 2026, ScienceLeadR ranks Pierre Vabres in the top 1% of experts worldwide for Congenital Abnormalities. Pierre Vabres has authored 417 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 1,078 (community average: 125). How the SLR is computed.

LeadR Profile

Pierre Vabres Centre Hospitalier Universitaire Dijon Bourgogne France
1 078 ScienceLeadR Reputation 1078

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

Centre Hospitalier Universitaire Dijon Bourgogne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 417

Citations

Citations: 16 551 1st author: 25 Last author: 86 Unique author: 7

Main journals

Ann Dermatol Venereol 139
Br J Dermatol 26
J Invest Dermatol 20
J Eur Acad Dermatol Venereol 14
Genet Med 12

Best Journals

Nature 3
Nat Med 2
Sci Immunol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Peripheral vasomotor symptoms: Expanding the phenotype of GNA11-related capillary malformations.
PMID 42755085 — sexually transmitted diseases, capillaries, mosaicism, phenotype, skin diseases, signs and symptoms		J Eur Acad Dermatol Venereol20260
Novel Postzygotic Variants Associated With Hypomelanosis of Ito Expand the ACTB-Related Neurocutaneous Disease Spectrum.
PMID 42206741 — hypopigmentation, phenotype, neurodevelopment		Clin Genet20260
Genetic sequencing strategy for the diagnosis of epidermal differentiation disorders: A cohort study.
PMID 42206543 — sexually transmitted diseases, whole genome sequencing, cohort studies, skin diseases, diagnosis		J Eur Acad Dermatol Venereol20260
Trametinib for multiple non-ossifying fibromas due to KRAS mosaic mutations: two case reports.
PMID 42151365 — fibroma, fibroma, ossifying, therapeutics, mutation		Commun Med (Lond)20260
"McCune Albright-like" syndrome due to a post-zygotic KRAS variant.
PMID 41373171 — dermatology		Clin Exp Dermatol20250

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 6
Phase 3 3
N/A 2
Phase 2/Phase 3 1

By status:

Completed 7
Recruiting 2
Unknown 2
Terminated 1

By type:

Interventional 11
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 2
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly CApillary Malformation Polymicrogyria Syndrome (MCAP)
NCT05577754 — megalencephaly, safety, blood, capillaries, blood specimen collection, spinal puncture, polymicrogyria, multiple chronic conditions, neurodevelopmental disorders, hereditary sensory and autonomic neuropathies, therapeutics, punctures, neurodevelopment		Phase 2Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS